Disclosures for "“Immuncompetent” PML in Context of Acquired Interferon Gamma Deficiency Treated with Pembrolizumab"
-
Dr. Mullane has nothing to disclose.
-
Dr. O'Rourke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.